THALIDOMIDE - EFFECT ON T-CELL SUBSETS AS A POSSIBLE MECHANISM OF ACTION

Authors:
  • BMB MONCADA
    B MONCADA
  • MBML BARANDA
    ML BARANDA
  • RGR GONZALEZAMARO
    R GONZALEZAMARO
  • RUR URBINA
    R URBINA
  • CLCE LOREDO
    CE LOREDO

  • 1 January 1985
    • journal article
    • research article
    • Vol. 53  (2) , 201-205
    • PMID:3874920
Abstract
Three lepromatous leprosy patients with erythema nodosum leprosum had their T helper populations significantly increased after thalidomide therapy. A 14-yr-old girl with Behcet''s syndrome showed a consistent decrease in Ia+ cells throughout her 3-mo. course of thalidomide therapy. The same findings were observed in 2 patients with the actinic prurigo type of polymorphous light eruption. Thus, thalidomide may act as an immunomodulating agent on T cell subsets.